Live from the NIH registry
Studies recruiting near San Antonio right now
Top 25 of 1,016 recruiting studies, sorted by proximity — each links to its official registry page
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Pheochromocytoma, Paraganglioma
N/A
Observational 2,000 participants sought
University of Texas Health Science Center — San Antonio, Texas (3.3 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Consultants of Texas — Schertz, Texas (16.5 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment
Peripheral Arterial Disease
N/A
Observational 150 participants sought
University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Kent Imaging Inc
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - South San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: R1 Therapeutics
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Kumquat Biosciences Inc.
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Dren Bio
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Medical Center Ophthalmology Associates — San Antonio, Texas (3.3 mi)
· Sponsor: Boehringer Ingelheim
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Pasithea Therapeutics Corp.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Texas Oncology - San Antonio ( Site 8009) — San Antonio, Texas (3.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The University of Texas Health Science Center San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Element Research Group — San Antonio, Texas (3.3 mi)
· Sponsor: Philip Morris Products S.A.
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
START San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Cartography Biosciences
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Texas Oncology - San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 3
Interventional 160 participants sought
MBX Biosciences Investigational Site — Shavano Park, Texas (8.6 mi)
· Sponsor: MBX Biosciences
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
UT Health San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: AC Immune SA
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Clinical Advancement Center — San Antonio, Texas (3.3 mi)
· Sponsor: Novo Nordisk A/S
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology - San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: SCRI Development Innovations, LLC
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — San Antonio, Texas (3.3 mi)
· Sponsor: AstraZeneca
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Texas Oncology San Antonio Medical Center — San Antonio, Texas (3.3 mi)
· Sponsor: Daiichi Sankyo
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — San Antonio, Texas (3.3 mi)
· Sponsor: Avenzo Therapeutics, Inc.
TMS for PTSD in Youth
Post Traumatic Stress Disorder (PTSD)
N/A
Interventional 20 participants sought
UT Health Department of Psychiatry — San Antonio, Texas (3.3 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm
Phase 3
Interventional 70 participants sought
Vanda Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Vanda Pharmaceuticals
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Breast Cancer
Phase 2
Interventional 36 participants sought
Texas Oncology- San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: SCRI Development Innovations, LLC